@article{e04e84a9f56c43979c84789f2a66c579,
title = "Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death",
abstract = "Pathogen recognition and TNF receptors signal via receptor interacting serine/threonine kinase-3 (RIPK3) to cause cell death, including MLKL-mediated necroptosis and caspase-8-dependent apoptosis. However, the post-translational control of RIPK3 is not fully understood. Using mass-spectrometry, we identified that RIPK3 is ubiquitylated on K469. The expression of mutant RIPK3 K469R demonstrated that RIPK3 ubiquitylation can limit both RIPK3-mediated apoptosis and necroptosis. The enhanced cell death of overexpressed RIPK3 K469R and activated endogenous RIPK3 correlated with an overall increase in RIPK3 ubiquitylation. Ripk3K469R/K469R mice challenged with Salmonella displayed enhanced bacterial loads and reduced serum IFNγ. However, Ripk3K469R/K469R macrophages and dermal fibroblasts were not sensitized to RIPK3-mediated apoptotic or necroptotic signaling suggesting that, in these cells, there is functional redundancy with alternate RIPK3 ubiquitin-modified sites. Consistent with this idea, the mutation of other ubiquitylated RIPK3 residues also increased RIPK3 hyper-ubiquitylation and cell death. Therefore, the targeted ubiquitylation of RIPK3 may act as either a brake or accelerator of RIPK3-dependent killing.",
keywords = "Cell biology, Molecular biology",
author = "Daniel Frank and Garnish, {Sarah E.} and Sandow, {Jarrod J.} and Ashley Weir and Lin Liu and Elise Clayer and Lizeth Meza and Maryam Rashidi and Cobbold, {Simon A.} and Scutts, {Simon R.} and Marcel Doerflinger and Holly Anderton and Lawlor, {Kate E.} and Najoua Lalaoui and Kueh, {Andrew J.} and Eng, {Vik Ven} and Ambrose, {Rebecca L.} and Herold, {Marco J.} and Samson, {Andre L.} and Rebecca Feltham and Murphy, {James M.} and Gregor Ebert and Pearson, {Jaclyn S.} and Vince, {James E.}",
note = "Funding: The generation of the Ripk3 K469R/K469R mice used in this study was supported by Phenomics Australia and the Australian Government through the National Collaborative Research Infrastructure Strategy ( NCRIS ) program. MJH is a National Health and Medical Research Council of Australia ( NHMRC ) Senior Research Fellow ( 1156095 ) and supported by the Leukemia and Lymphoma Society SCOR grant 7015-18 . K.E.L was supported by NHMRC project grants ( 1145788 , 1162765 ) and ideas grant ( 1181089 ), and is an Australian Research Council ( ARC ) Future Fellow ( FT19100266 ); JEV was supported by NHMRC project grants ( 1145788 and 1101405 ), an ideas grant ( 1183070 ), a fellowship ( 1141466 ) and an investigator grant ( 2008692 ); ALS was supported by NHMRC ideas grant ( 2002965 ); JMM was supported by an NHMRC grant ( 1172929 ).",
year = "2022",
month = jul,
day = "15",
doi = "10.1016/j.isci.2022.104632",
language = "English",
volume = "25",
pages = "1--28",
journal = "iScience",
issn = "2589-0042",
publisher = "Elsevier Inc.",
number = "7",
}